ClinicalTrials.Veeva

Menu

Impact of Hospitalization on High-sensitivity Cardiac Troponin T Concentrations Depending on Disease Severity

U

University of Leipzig

Status

Completed

Conditions

Non-cardiac Disease

Treatments

Diagnostic Test: Analysis of hs-cTnT serum concentration at hospitalization
Diagnostic Test: Analysis of hs-cTnT serum concentration after discharge

Study type

Observational

Funder types

Other

Identifiers

NCT04963400
RL_2021_1

Details and patient eligibility

About

We aim to examine, whether hospitalization is associated with higher high-sensitivity cardiac troponin T (hs-cTnT) serum concentrations in patients without a cardiac disease.

Full description

High-sensitivity cardiac troponin T (hs-cTnT) values will be obtained in hospitalized patients a) without a diagnosed or suspected cardiac disease, and b) with an acute medical condition that is not commonly associated with an increase of hs-cTnT concentrations. As a reference, a second sampling of blood for an analysis of the hs-cTnT serum concentration will be obtained in the same patients after discharge (60 days after hospitalization).

Enrollment

177 patients

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • hospitalization due to a non-cardiac disease
  • age ≥ 50 years

Exclusion criteria

  • diagnosed or suspected cardiac disease
  • acute medical conditions commonly associated with a myocardial injury (e.g. circulatory shock, sepsis, pulmonary embolism, cerebral infarction, acute renal failure)

Trial design

177 participants in 3 patient groups

Patients with low disease severity
Description:
Hospitalized patients without a diagnosed or suspected cardiac disease and with an acute medical condition of low severity (e.g. patients with retinal detachment)
Treatment:
Diagnostic Test: Analysis of hs-cTnT serum concentration at hospitalization
Diagnostic Test: Analysis of hs-cTnT serum concentration after discharge
Patients with medium disease severity
Description:
Hospitalized patients without a diagnosed or suspected cardiac disease and with an acute medical condition of medium severity (e.g. patients with an uncomplicated acute pancreatitis oder an acute exacerbation of a chronic inflammatory bowel disease)
Treatment:
Diagnostic Test: Analysis of hs-cTnT serum concentration at hospitalization
Diagnostic Test: Analysis of hs-cTnT serum concentration after discharge
Patients with high disease severity
Description:
Hospitalized patients without a diagnosed or suspected cardiac disease and with an acute medical condition of high severity (e.g. patients with a proximal femoral fracture)
Treatment:
Diagnostic Test: Analysis of hs-cTnT serum concentration at hospitalization
Diagnostic Test: Analysis of hs-cTnT serum concentration after discharge

Trial contacts and locations

1

Loading...

Central trial contact

Romy Langhammer, MD; Rolf Wachter, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems